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Introduction
The majority of the Lebanese water resources are polluted due to the absence of strict regulations
from concerned parties. The main cause of water pollution in Lebanon is sewage and wastewater.
These are being discharged directly into the aquatic environment or only after primary treatment
by Wastewater Treatment Plants (WWTPs) (1). Environmental risk factors can be one of the
reasons behind the increase and the appearance of numerous diseases, including cancer (2). In
fact, the incidence of cancer in Lebanon, is still increasing from the time when the initial records
on cancer occurrence were reported in 1966 (3). Hence, the consumption rate of anticancer drugs
is on the rise.
According to oncologists, the top 6 most reoccurring types of cancer in Lebanon are: Breast
Cancer, Prostate Cancer, Lung Cancer, Colon Cancer, Non-Hodgkin’s Lymphoma and Bladder
Cancer. Therefore, six anticancer drugs estimated to be among the most administered in Lebanon
were selected for the method development (Figure 1).
Objectives
Develop and validate a method to evaluate the occurrence of selected anticancer drugs in hospital
effluents, WWTPs influent and effluent, and in surface water using SPE, HPLC, LC/MS techniques.
Materials & Methods
The analytical standards: Cyclophosphamide (≥98%), Tamoxifen (≥98%), 5-fluorouracil (≥99%)
and the European Pharmacopoeia (EP) Reference Standards: Gemcitabine Hydrochloride,
Docetaxel Trihydrate, and Methotrexate were purchased from Sigma Aldrich, UK. Isotopically
labelled caffeine, used as internal standard, 13C3-Caffeine (99atom %13C) in a methanol solution
of 1mg/ml and formic acid reagent grade (≥95%), were supplied by Sigma Aldrich, UK. HPLC-
grade methanol and LC-MS grade water were obtained from VWR Chemicals, UK.
Stock solutions of each compound were prepared in LC-MS grade water. The separation of the
compounds was achieved on an Agilent 1200 series HPLC (Infinity II) (Figure 2) using Kinetex 2.6
μm Phenyl-Hexyl column (100 x 3 mm) purchased from Phenomenex, UK. Gradient elution was
performed with a binary mobile phase at a flow rate 0.3 ml/min using (A) water with 0.1% formic
acid and (B) methanol with 0.1% formic acid.
Results & Discussion
The compounds eluted were: (1) 5-Fluorouracil, (2) Gemcitabine, (3) Methotrexate, (4) Caffeine,
(5) Tamoxifen and (6) Docetaxel (Figure 3).
However, the selection of the right wavelength was difficult as all these compounds have
various structures and therefore, different spectra and molar absorbtivities. Also,
Cyclophosphamide was not detected by this method due to its limited absorption of UV
radiation (4).
The developed method (Table 1) allowed the separation of five anticancer drugs and caffeine 
as internal standard within 20 minutes. 
Conclusion & Future Work
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